Pharma Tweeting: Five Twitter Moments That Highlight The Perils Of The Platform
Scrip takes a broad look at some controversial Twitter moments that pharma should be watchful of - words once let out of the cage cannot be whistled back again.
You may also be interested in...
Years after a scathing Indian parliamentary report flagged concerns around regulatory lapses for drug approvals, an expert panel has endorsed the continued marketing of ambrisentan and everolimus in the country. But dronedarone, also featured in the report, is no longer sold by Sanofi in India.